475 results about "Pyrrolidine" patented technology

The invention discloses an indole-benzothiadiazole derivative as well as a preparation method and application thereof. The general structural formula of the indole-benzothiadiazole derivative provided by the invention is shown in the specification, wherein R is selected from one of methyl piperazinyl, diethylamino, azetidinyl and pyrrolidinyl. The derivative can be specifically combined and fluorescently labeled with mitochondrial RNA in cells, and has good selectivity, high fluorescence signal-to-noise ratio and excellent anti-interference capability in a complex biological system. Meanwhile, the indole-benzothiadiazole derivative provided by the invention is simple in synthetic route, easily available in raw materials, good in stability and convenient to store and use, can be specifically combined with RNA and generate strong fluorescence response, is suitable for real-time detection and imaging of in-vitro and in-vivo mitochondrial RNA, and is an efficient mitochondrial RNA micromolecular fluorescent probe.

Described herein are lithium-metal rechargeable electrochemical cells comprising a lithium-metal negative electrode, a positive electrode, and a liquid electrolyte. The liquid electrolyte comprises a core mixture and a diluent. The diluent comprises a fluorinated ether. The core mixture comprises a set of salts and a set of solvents. The set of solvents comprises a pyrrolidinium-containing ionic liquid and a molecular solvent. The molecular solvent is a non-fluorinated ether, for example including but not limited to 1,2-dimethoxyethane. In some examples, the electrolyte further comprises an electrolyte additive, for example including but not limited to tris(trimethylsilyl)phosphate. In some examples, the set of salts comprises one or more imide-containing lithium salts. In some examples, the set of salts comprises lithium bis(fluorosulfonyl)imide and an additional salt and the mole fraction of lithium bis(fluorosulfonyl)imide in the set of salts is 0.5 or greater.

The invention discloses a fullerene pyrrolidine derivative as well as a preparation method and application thereof, and relates to the field of photoelectric functional materials. The structural general formula of the fullerene pyrrolidine derivative is # imgabs0, and fullerene, amino acids with different carbon chain lengths and aromatic aldehyde are subjected to Prato reaction to generate the fullerene pyrrolidine derivative. The fullerene pyrrolidine derivative provided by the invention is used as an electron transport layer material, can significantly improve the performance of a photoelectric device, has excellent chemical stability and environmental adaptability, and greatly enhances the stability of the device. In addition, the preparation method of the fullerene pyrrolidine derivative is simple, convenient and efficient, the operation condition is mild, and the manufacturing cost of a device is reduced.

The invention provides an anti-hair-loss and hair-growing product containing plant extract components and a preparation method thereof, and relates to the field of wash supplies, the anti-hair-loss and hair-growing product is prepared from the following raw materials by weight: 50-80 parts of water, 5-10 parts of propylene glycol, 1-5 parts of 1, 3-propylene glycol, 1-5 parts of 1, 3-propylene glycol, and 1-5 parts of 1, 3-propylene glycol. The composition is prepared from the following components in parts by weight: 0.1 to 1 part of 1, 2-pentanediol, 0.1 to 1 part of pyrrolidinyl diaminopyrimidine oxide, 0.1 to 0.5 part of diaminopyrimidine oxide, 0.01 to 0.02 part of caffeine, 0.01 to 0.1 part of adenosine, 0.05 to 0.2 part of vitamin B6, 0.01 to 0.5 part of biotin tripeptide-1, 0.1 to 1 part of dipotassium glycyrrhizinate, 0.02 to 0.05 part of ethylenediamine tetraacetic acid, 0.1 to 1 part of D panthenol, 0.2 to 1 part of p-hydroxyacetophenone, 0.01 to 1 part of 1, 2-pentanediol, 0.1 to 1 part of 1, 2-pentanediol, 0.1 to 1 part of 2, 2-pentanediol, 0.1 to 1 part of 2, 2-pentanediol, 0.1 to 1 part of 2, 2- The composition comprises the following components in parts by weight: 1-2 parts of 1, 2-hexanediol, 0.1-0.5 part of citric acid, 1-2 parts of 1, 3-butanediol, 0.01-1 part of NMN and 3-5 parts of a plant extract. According to the present invention, the extraction method of the plant extract in the raw materials is specifically adjusted so as to significantly reduce the content of the pigment and the odor substance in the extract, such that the obtained hair growing liquid has characteristics of good hair growing effect, light color and light drug taste, can be easily accepted by consumers, and is suitable for large-scale promotion and application.

Described herein are compounds of Formula (I): I and their pharmaceutically acceptable salts, wherein R1, R2, R3, Rp, A1, L1, L2, T1, T2, T3, T4, n1, t1, t2, and t3 are defined herein; their use as GIPR antagonists; pharmaceutical compositions containing such compounds and salts; and the use of such compounds and salts to treat or prevent, for example, obesity, weight gain, and / or T2DM.

The invention discloses an application of a novel miscellaneous [3] aromatic hydrocarbon crystal material in adsorptive separation of a pyrrolidine and tetrahydrofuran mixture and / or capture of iodine vapor, and relates to the technical field of adsorption.Firstly, the novel miscellaneous [3] aromatic hydrocarbon crystal material capable of adsorptive separation of pyrrolidine and tetrahydrofuran so as to realize iodine capture is synthesized; the application method comprises the following steps: selectively adsorbing pyrrolidine in a mixture of pyrrolidine and tetrahydrofuran by adopting the novel miscellaneous [3] aromatic hydrocarbon crystal material to obtain a pyrrolidine-miscellaneous [3] aromatic hydrocarbon crystal material, realizing separation of tetrahydrofuran and pyrrolidine, and capturing iodine vapor by adopting the pyrrolidine-miscellaneous [3] aromatic hydrocarbon crystal material. Compared with other macrocyclic aromatic hydrocarbons, the method provided by the invention not only can realize separation of tetrahydrofuran and pyrrolidine, but also has the advantages of high iodine adsorption capacity, good thermal stability and the like; meanwhile, the synthesis method has the advantages of simplicity in operation, high yield, simplicity in post-treatment, easiness in separation and purification of products and the like.

The present invention relates to pharmaceutical compositions containing N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3, 3-trifluoro-2,2-dimethyl-propoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide, a solid dispersion of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-7V-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-en indol-5-yl)cyclopropanecarboxamide, and a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-quinoline-3-carboxamide, including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical compositions.

The invention relates to the technical field of wafer packaging, and particularly discloses wafer-level packaging copper interconnection electroplating liquid and a wafer-level packaging interconnection electroplating process. According to the application, the growth of copper at an orifice is inhibited by utilizing the synergistic effect among the components such as the ammonium pyrrolidine dithiocarbamate, the chloride ions, the copper salt and the polyethylene glycol, and the thickness of a copper plating layer on the surface of the cathode is reduced by adding the anthraquinone sulfonate; and the thickness of the plating layer in the center of the through hole is increased through the synergistic effect of anthraquinone sulfonate, the leveling agent, the accelerator, the brightening agent and the inhibitor, so that the through hole can be effectively filled under the high current density, the good deep plating capacity is achieved, and the product quality can be fully improved.

The invention provides a fullerene pyrrolidine enantiomer mediated cholesteric liquid crystal with circular polarization luminescence property and nonlinear anti-saturated absorption property, and a preparation method and application thereof. The method comprises the following steps: dissolving C60, paraformaldehyde and (R / S)-(+ / -)-alpha-methylbenzylamine in an organic solvent, and carrying out heating reflux reaction to obtain fullerene pyrrolidine enantiomer molecules; dissolving in carbon disulfide to obtain an enantiomer solution; dissolving achiral dye molecules in a solvent to obtain a dye solution; and dropwise adding the enantiomer solution and the dye solution into thermotropic liquid crystal molecules, and drying to obtain the thermotropic liquid crystal. The method is simple, the obtained cholesteric liquid crystal system shows a characteristic fingerprint texture and has a periodic spiral structure, and the doping proportion of chiral molecules is easy to adjust; the composite system has good time stability and is not prone to phase separation; the liquid crystal platform shows good circular polarization luminescence performance and third-order nonlinear optical property, and is a cholesteric liquid crystal platform with an integrated function.

The invention relates to the technical field of ionic liquid synthesis and catalytic synthesis of hydroxybutyl acrylate, in particular to a functional double-acid supported ionic liquid as well as a preparation method and application thereof. The functional double-acid supported ionic liquid comprises an MOFs (Metal-Organic Frameworks) material UiO-66-SO3H and a double-acid ionic liquid supported on the MOFs material. The synthesis of the double-acidified ionic liquid comprises the following steps: synthesizing a dimethyl monomer by adopting imidazole, pyrrolidine or morpholine; reacting the dimethyl monomer with 1, 4-butane sultone to generate sulfonic acid inner salt; and acidifying sulfonic acid internal hydrochloric acid. The functionalized double-acid supported ionic liquid has the advantages that the heat stability and the reusability are good; the product is immiscible with an organic reaction solvent and is easier to separate and recover; as a catalyst for catalyzing esterification reaction, the catalytic activity is obviously improved; as a solid catalyst in an esterification reaction, the catalyst can be applied to a fixed bed reactor, continuous esterification is realized, and the productivity is improved.

The invention provides a pyrrolidinyl diaminopyrimidine oxide supramolecular nano-vesicle as well as a preparation method and application thereof, and relates to the technical field of cosmetics. Comprising the following components: pyrrolidinyl diaminopyrimidine oxide, glycyrrhizic acid, acetyl tetrapeptide-2, a cosolvent and a solvent, the prepared pyrrolidinyl diaminopyrimidine oxide supramolecular nanovesicles can significantly improve the solubility and hair follicle targeting property of pyrrolidinyl diaminopyrimidine oxide, have the advantages of high encapsulation efficiency, large drug loading capacity, good stability and high safety, can effectively promote the anti-hair loss active factor pyrrolidinyl diaminopyrimidine oxide to accurately act on hair follicle cells, and can effectively inhibit hair loss. And the efficient anti-falling effect is achieved. The pyrrolidinyl diaminopyrimidine oxide supramolecular nano-vesicle provided by the invention is simple in preparation process, accurate in dosage and suitable for large-scale production.

A medicament for treatment or prevention of interstitial lung disease, and of a disease or symptom accompanied by systemic sclerosis in a subject, the medicament comprising, as an effective ingredient, 1-{2-[(3S,4R)-1-{[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidin-3-yl]carbonyl}-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt or co-crystal thereof.

The invention discloses an extraction head and a method for detecting organochlorine pesticides in water by using the extraction head. According to the preparation method, 4-hydroxycarbazole is taken as a functional monomer for electro-polymerization, (benzotriazole-1-yloxy) dipyrrolidine carbon hexafluorophosphate ionic liquid (IL) is taken as a doping medium, and the composite extraction coating is obtained in an electrochemical co-deposition mode. The polymerization 4-Hydroxycarbazole-IL (HBPyU) with the ionic liquid concentration of 25 mu g / mL, the salt solution of 35% saturated sodium chloride solution, the stirring rate of 600 r / min, the extraction temperature of 50 DEG C and the extraction time of 30 min is used as an optimal extraction head, and organochlorine pesticides Hepache and Quintozene in water are analyzed and detected. Therefore, according to the technical scheme, compared with an extraction head only provided with a monomer, the coating material added with the ionic liquid has the best extraction capacity on an analyte, and the beneficial effects of high efficiency and high sensitivity are achieved.

The application discloses a kind of ultraviolet absorber with triazine ring as main structure and its preparation method and its application in aramid fiber, the ultraviolet absorber has the following structural formula: Wherein, R1, R2, R3, R4 It is the group containing phenyl or substituted phenyl, R5 It is piperidyl, piperazyl, pyrrolidinyl and one of the following structures:This ultraviolet absorber has good absorption to UVA-UVB band ultraviolet, especially in 290~320 nm range has good ultraviolet absorption, adding the ultraviolet absorber in aramid fiber can significantly improve its weather resistance and service life, keep mechanical property, delay ultraviolet degradation, reduce the direct damage of fiber.

The technology herein provides various embodiments that relate to a method of treating pulmonary hypertension in a subject in need thereof, comprising administering to the subject an effective amount of BX-912 (N-[3-[[5-bromo-4-[2-(1H-imidazol-5-yl)ethylamino]-2-pyrimidinyl]amino]phenyl]pyrrolidine-1-carboxamide).

Described is small molecule 6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)-4-(tetrahydro-2H-pyran-4-yl)quinolin-2-amine (MS152) that inhibits methyltransferases G9a / EHMT2. This inhibitor can be used for the treatment of patients with G9a / EHMT2 related diseases such as Prader-Willi Syndrome and Alzheimer's Disease. Formula (I).

The invention discloses weather-resistant and medium-resistant alkyd resin varnish and a preparation method thereof. The varnish is prepared from the following raw materials: modified alkyd resin, a composite drier, zirconium iso-octoate with the purity of 12%, an anti-skinning agent, 200 # solvent oil and xylene. The modified alkyd resin is prepared from the following raw materials: soya oil acid, pentaerythritol, benzoic acid, pyrrolidine-2-one-1-acetic acid, dimethylbenzene and a 200 # solvent. According to the invention, pyrrolidine-2-ketone-1-acetic acid is used as a binary acid component to partially or completely replace traditional phthalic anhydride, so that the reaction efficiency of alkyd resin synthesis can be improved, and the problems of yellowing, pulverization and poor water resistance of traditional alkyd resin can be solved; according to the varnish prepared by the invention, on the basis of maintaining the inherent gloss, flexibility and constructability of alkyd resin, the key properties such as weather resistance, water resistance and acid resistance are improved; the whole preparation process of the varnish continues to use mature alkyd resin production equipment and flow, and has good economical efficiency and industrial popularization prospects.

An aerosol generating material for use in an aerosol delivery device is provided, the aerosol generating material including a fibrous plant material, an aerosol former, and an active agent including at least a substituted 3-(1-methylpyrrolidin-2-yl)pyridine, a 3-(azetidin-2- yl)pyridine, or a 3-(azetidin-2-ylmethoxy)pyridine. The active agent is absorbed or adsorbed in or on the fibrous plant material. The disclosure further provides devices and aerosol provision systems incorporating such aerosol generating material.

The present invention discloses a small molecule compound having a substituted phenylspiro[indoline-3,3'-pyrrolidine] structure, the structure of which is shown in General Formula I, and the definitions of each substituent as described in the specification and claims. The compound of the present invention can inhibit the protein-protein interactions of MDM2-p53 and MDMX-p53 proteins. As a small molecule inhibitor of the protein-protein interactions of MDM2-p53 and MDMX-p53 proteins, it is used in the preparation of a drug for preventing and / or treating diseases related to MDM2 and MDMX, particularly tumors.

The invention provides an electrolyte additive and application thereof, the electrolyte additive comprises a pyrrolidine nitrate compound, and the pyrrolidine nitrate compound has a structure as shown in a formula I: # imgabs0 # formula I, wherein R1, R2, R3, R4, R5 and R6 are respectively and independently selected from one of hydrogen, halogen, linear alkyl, substituted linear alkyl, branched alkyl, substituted branched alkyl, alkoxy, substituted alkoxy, heterocyclic group, substituted heterocyclic group and the like. According to the electrolyte additive disclosed by the invention, the nitrate anions and the pyrrolidinyl cations are contained, and the nitrate anions can form SEI on a negative electrode to improve the stability of a negative electrode interface and enter a solvation structure of lithium ions in the electrolyte to reduce the desolvation energy of the lithium ions; meanwhile, nitrate ions and pyrrolidinyl cations both have excellent oxidation resistance and can be compatible with a high-voltage positive electrode, so that the fast charging performance of the battery is improved on the premise of not sacrificing the service life of the battery.

This invention discloses a chiral [oxyindole-pyrrolidine-β-lactam] bispirocyclic compound containing trifluoromethyl groups, with the following structural formula: The preparation includes the following steps: 1. Sequentially adding a metal catalyst, a chiral ligand, a base, indigo-derived trifluoromethylimine ylide, and 3-methylene β-lactam, followed by the addition of an organic solvent to obtain a mixture. The mixture is stirred at a reaction temperature of 0℃ to 50℃. 2. After the reaction is complete, the chiral [oxyindole-pyrrolidine-β-lactam] bispirocyclic compound containing trifluoromethyl groups is obtained through post-processing. The chiral [oxyindole-pyrrolidine-β-lactam] bispirocyclic compound containing trifluoromethyl groups prepared in this application lays a material foundation for in-depth drug activity research based on new drug development.

The present invention relates to a new process for the preparation of (3R)-3-fluoropyrrolidine hydrochloride or an acceptable salts thereof via a N-Boc-(3S)-3-hydroxypyrrolidine intermediate. The process is suitable for the synthesis of N-Boc-(3S)-3-hydroxypyrrolidine at technical scale in high, not less than 99.85%-a / a optical purity and a purity of not less than 99.8%-a / a. The high quality N-Boc-(3S)-3-hydroxypyrrolidine can be converted to (3R)-3-fluoropyrrolidine hydrochloride exhibiting an optical purity of not less than 99.95%-a / a and a purity of not less than 99.5%-a / a thus making it a suitable intermediate for manufacturing of pharmaceutical active compounds.

The application discloses a preparation method of 1-(2-aminoethyl) pyrrolidine and belongs to the field of chemical synthesis. The application provides a novel synthesis method of 1-(2-aminoethyl) pyrrolidine, which is prepared from 1,2-dichloroethane and pyrrolidine as raw materials, addition of a solvent and alkali, heating reaction, extraction, acidification and reduced-pressure distillation after the reaction is finished to obtain N-(2-chloroethyl) pyrrolidine solution; N-(2-chloroethyl) pyrrolidine and ammonia water are used as raw materials, high-pressure heating reaction is carried out, extraction and reduced-pressure distillation are carried out after the reaction is finished to generate 1-(2-aminoethyl) pyrrolidine. The application has the advantages of simple operation process, green process synthesis, convenient product purification and high product purity.

Use of a composition containing a 5-oxo-pyrrolidine-2-carboxylic acid derivative with formula IIa for the fixation and optional preservation of biological organs and / or tissues and / or whole body specimens and / or corpses.

The present invention relates to compounds of formula (I) or formula (II) or pharmaceutically acceptable salt, solvate or hydrate thereof, wherein said compound of formula (I) and said compound of formula II each comprises at least one ONO2 or ONO moiety; R1 is C1-C3alkyl; R2 is H, C1-C6alkyl, C3-C6cycloalkyl, C1-C2alkoxy, C2-C4alkenyl; R3 is C1-C4alkyl optionally substituted with C1-C2alkoxy, C3-C4cycloalkyl, C2-C4alkenyl; R4 and R5 are each independently H or C1-C6alkyl optionally substituted with F, OH, ONO, ONO2, COOH, C1-C3alkoxy, C3-C6cycloalkyl; or together with the nitrogen atom to which they are attached form a heterocyclic ring, wherein preferably said heterocyclic ring is selected from aziridine, azetidine, pyrollidine, piperidine, morpholine, piperazine, homo-piperazine, 2,5-diazabicyclo[2,2,1]heptane and 3,7-diazabicyclo[3,3,0]octane, wherein said heterocyclic ring is optionally substituted with independently one or more R6; R6 is C1-C6alkyl optionally substituted with independently one or more halogen, OH, ONO, ONO2, C1-C3alkoxy, C1-C3haloalkoxy, COOR7, NR8R9, C═NR10; R7 is H, or C1-C4alkyl optionally substituted with F, OH, ONO, ONO2, NR8R9; R8 and R9 are independently H, or C1-C4alkyl optionally substituted with ONO, ONO2; R10 is C1-C4alkyl optionally substituted with F, ONO, ONO2; C3-C6cycloalkyl; pharmaceutical compositions thereof, and their use in methods of treating or preventing a disease alleviated by inhibition of PDE5 in a human or in a non-human mammal.

The invention relates to a compound of formula (I) wherein n = 1 or 2, A and A'are independently selected from the group consisting of the following substituents (II-a) and (II-b), R and R 'are independently selected from H and a linear or branched C1-C3 alkyl group, Z is selected from a linear or branched C1-C4 alkyl group and an aryl group optionally substituted by a linear or branched C1-C3 alkyl group and / or by a hydroxyl group, and the structural unit of formula (N) is selected from the following structural units (III-a), (III-b), (III-c), (III-d) and (III-e) wherein for each structural unit (III-a), (III-b), (III-c), (III-d) and (III-e), Ra, Rb, Rc and Rd are independently selected from a linear or branched C1-C4 alkyl group. .

The invention discloses a method for synthesizing dipeptide Fmoc-Leu-Aib-OH, and belongs to the field of polypeptide synthesis, the specific preparation method comprises the following steps: under the action of organic alkali and an activating reagent, Fmoc-Leu-OH and H-Aib-OH react to obtain the dipeptide Fmoc-Leu-Aib-OH; the activating reagent comprises at least one of N, N, N ', N'-tetramethyl chloroformamidine hexafluorophosphate, 2-(7-azabenzotriazole)-N, N, N ', N'-tetramethyl urea hexafluorophosphate and benzotriazole-1-yl-oxytripyrrolidinyl phosphorus hexafluorophosphate, and the organic base comprises at least one of N-methylimidazole, N, N-diisopropylethylamine and pyridine. The dipeptide Fmoc-Leu-Aib-OH prepared by the preparation method disclosed by the invention is high in yield, high in purity and high in raw material conversion rate.

The application discloses an imine reductase PmIR mutant and a preparation method and application of (R)-5-fluoro-2-methoxy-3-(pyrrolidin-2-yl)pyridine ((R)-FMPP) in the mutant, wherein the mutant is any one of single-point or combined mutation of glutamine at position 138, proline at position 140, glutamine at position 190, tryptophan at position 195, serine at position 228 and arginine at position 251 of imine reductase PmIR, and the amino acid sequence of the parent is shown in SEQ ID NO. 2.

Aerosol generating articles adapted for use in an aerosol delivery device are provided. The aerosol generating articles include an aerosol generating material and an aerosol-modifying agent, wherein the aerosol-modifying agent includes a substituted 3-(1-methylpyrrolidin-2- yl)pyridine, a 3-(azetidin-2-yl)pyridine, or a 3-(azetidin-2-ylmethoxy)pyridine. The disclosure further provides devices incorporating such aerosol generating articles.

The invention discloses a battery monomer, an isolating membrane, a preparation method of the isolating membrane, a battery device and a power utilization device, the battery monomer comprises the isolating membrane and electrolyte, and the isolating membrane comprises a porous base membrane; the coating is arranged on at least one side of the porous base membrane and comprises a polymer additive, and the polymer additive comprises a first functional group and a second functional group; the first functional group comprises one or more of bis (fluorosulfonyl) imino group, bis (trifluoromethyl) sulfonyl imino group, trifluoroboric acid group, hexafluorophosphoric acid group, sulfonic acid group, hexafluoroarsenate group, trifluoromethanesulfonic acid group, difluorophosphoric acid group, bis (oxalato) boric acid group, difluoro (oxalato) boric acid group, difluoro (oxalato) phosphoric acid group, tetrafluoro (oxalato) phosphoric acid group and imidazolyl; the second functional group comprises one or more of quaternary ammonium ions, pyrrolidinyl, pyrrolyl, piperidinyl, pyridyl and imidazolyl. The battery monomer has good dynamic performance; the invention provides the isolating membrane for realizing the beneficial effects of the battery monomer, the preparation method of the isolating membrane, the battery device and the power utilization device.